Again the second year Minskintercaps admires the visitors of forum by the scale of its stand: on the area of 50.2 m2 there are information zones where the representatives of the Company showed the innovative products of 2018 registered in the Ministry of health of the Republic of Belarus: drugs Simet 40 mg and 80 mg, Relicaps advance, innovated rectal capsules.
Within an official opening of the exhibition Minister of health of the Republic of Belarus Valery Malashko, Vice Minister Igor Lositsky, Vice Minister Viacheslav Shilo and Director General of Control Company of Holding Belpharmprom Valery Shevchuk were the guests of our stand. Irina Podobed, Director of Minskintercaps spoke about the plans of the Company in 2018.
On the 28th of March, the second exhibition day, BelMAPO invited gynecologists to the lecture on “Modern approaches to therapy of vulvovaginal infections” hold in conference hall #3. The lecturer was Larissa Nebyshinets c.m.s., associate professor of obstetrics and gynecology Department of BelMAPO. Almost 50 gynecologists of the country were informed about the latest studies and actual methods of therapy of vulvovaginal infections. As usual there was time for additional questions consenting to extend the discussion on the main issues of seminar.
Specialists of exhibition stand of Minskintercaps noted significantly less visitors in the first half of the second day against the opening event, however, the flow of guests increased after afternoon. And these are not only doctors, pharmacists, provisors-pharmaceutists but actual and potential partners of the Company.
On March 29 Minskintercaps invited all interested to visit the enterprise within excursion-seminar. The guests saw production shops, appraised European approach to technological processes. “Drugs of Minskintercaps: probative
Resuming it can be stated that the program of the 25th jubilee forum-exposition Healthcare of Belarus was of interest and rich of events; our specialists gained inspirational experience in communicating the guests of the exhibition and identified vectors of partnership with potential clients of Company.